"Designing Growth Strategies is in our DNA"

Nanomedicine Market Size, Share & Industry Analysis, By Type (Therapeutics {Biologics and Small Molecules}, Diagnostics {IVD, Imaging, and Others}, and Medical Devices {Regenerative Medicine, and Implants}), By Molecule Type (Nanoparticles {Lipid Based, Polymers & Polymer Drug Conjugates, Inorganic Nanoparticles}, Nanoshells, Nanotubes, and Nanodevices) By Application (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Immunology, Infectious Diseases), By End-user (Hospitals and Clinics, Diagnostics Laboratories, Research and Academic Institutes), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI110983

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year 

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Unit

Value (USD billion)

Growth Rate

CAGR of 11.7% from 2025-2032

Segmentation

By Type

  • Therapeutics
    • Biologics
    • Small Molecules
  • Diagnostics
    • IVD
    • Imaging
    • Others
  • Medical Devices
    • Regenerative Medicine
    • Implants

By Molecule Type

  • Nanoparticles
    • Lipid-Based
    • Polymers & Polymer Drug Conjugates
    • Inorganic Nanoparticles
    • Others
  • Nanoshells
  • Nanotubes
  • Nanodevices

By Application

  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Immunology
  • Infectious Diseases
  • Others

By End-user

  • Hospitals and Clinics
  • Diagnostics Laboratories
  • Research and Academic Institutes
  • Others

By Geography

  • North America (By Type, By Molecule Type, By Application, By End-user, and By Country)
    • U.S.
    • Canada
  • Europe ( By Type, By Molecule Type, By Application, By End-user, and By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Type, By Molecule Type, By Application, By End-user, and By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America ( By Type, By Molecule Type, By Application, By End-user, and By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa ( By Type, By Molecule Type, By Application, By End-user, and By Country/Sub-Region)
    • GCC
    • South Africa
  • Rest of Middle East & Africa

 

  • 2019-2032
  • 2024
  • 2019-2023
  • 200
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann